Tele-Rehabilitation for Concussion
Trial Summary
What is the purpose of this trial?
The goal of this clinical trial is to examine the feasibility, utility, and efficacy of a smartphone-based assessment battery and remotely administered virtual Neuromuscular/Dual-Task (vNDT) intervention among healthy U.S. military service members and physically active young adults with a recent concussion.
Do I need to stop my current medications for the trial?
The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your doctor.
What data supports the effectiveness of the treatment Virtual Neuromuscular/Dual-Task Training for concussion?
Research shows that telerehabilitation, which includes virtual environments and multitasking, can help improve recovery in people with brain injuries. For example, a study found that a virtual rehabilitation program helped a person with head trauma improve balance and confidence, allowing them to return to full duty. This suggests that similar virtual treatments could be effective for concussions.12345
Is tele-rehabilitation generally safe for humans?
The available research suggests that tele-rehabilitation, including for conditions like traumatic brain injury and multiple sclerosis, is generally safe and can provide outcomes similar to traditional in-person rehabilitation. However, more large-scale studies are needed to fully establish its safety and effectiveness for routine use.25678
How is the treatment Virtual Neuromuscular/Dual-Task Training for concussion different from other treatments?
Virtual Neuromuscular/Dual-Task Training is unique because it uses a virtual environment to combine physical and cognitive exercises, allowing patients to practice tasks that challenge both their body and mind. This approach can be more accessible as it is delivered remotely, making it easier for patients to receive therapy without needing to travel to a clinic.12579
Research Team
David R Howell, PhD
Principal Investigator
University of Colorado School of Medicine
Eligibility Criteria
This trial is for U.S. military members and active young adults aged 18-40 who've had a mild traumatic brain injury (TBI) or concussion recently, diagnosed by a physician. They must have been physically active before the injury and own a smartphone to download an app.Inclusion Criteria
Exclusion Criteria
Trial Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive the virtual Neuromuscular/Dual-Task Training (vNDTT) intervention for 8 weeks
Follow-up
Participants are monitored for safety and effectiveness after treatment, including assessments of musculoskeletal injury rate and quality of life
Treatment Details
Interventions
- Virtual Neuromuscular/Dual-Task Training (Behavioral Intervention)
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Colorado, Denver
Lead Sponsor
Aviva Abosch
University of Colorado, Denver
Chief Medical Officer since 2019
MD
Uday B. Kompella
University of Colorado, Denver
Chief Executive Officer since 2015
PhD in Pharmaceutical Sciences
Binghamton University
Collaborator
Brooke Army Medical Center
Collaborator
Col. Mark Stackle
Brooke Army Medical Center
Chief Executive Officer since 2024
MD
Col. Sean Hipp
Brooke Army Medical Center
Chief Medical Officer since 2024
MD